COVID-19 pandemic and allergen immunotherapy—an EAACI survey

Oliver Pfaar*, Ioana Agache, Matteo Bonini, Helen Annaruth Brough, Tomás Chivato, Stefano R. Del Giacco, Radoslaw Gawlik, Aslı Gelincik, Karin Hoffmann-Sommergruber, Marek Jutel, Ludger Klimek, Edward F. Knol, Antti Lauerma, Markus Ollert, Liam O’Mahony, Charlotte G. Mortz, Oscar Palomares, Carmen Riggioni, Jürgen Schwarze, Isabel SkypalaMaría José Torres, Eva Untersmayr, Jolanta Walusiak-Skorupa, Adam Chaker, Mattia Giovannini, Enrico Heffler, Erika Jensen-Jarolim, Cristina Quecchia, Mónica Sandoval-Ruballos, Umit Sahiner, Vesna Tomić Spirić, Montserrat Alvaro-Lozano

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)

Fingerprint

Dive into the research topics of 'COVID-19 pandemic and allergen immunotherapy—an EAACI survey'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science